Walmart and Sam’s Club: Prescriptions Without New Requests

Walmart and Sam’s Club agreed to pay $825,000 in an automatic refill Medicaid settlement over allegations that their pharmacies billed Minnesota’s program for prescriptions without the beneficiary request required for each refill. The money was divided equally between the federal government and Minnesota, which jointly fund the program.

The Justice Department announced the resolution on May 29, 2018. This pharmaceutical fraud case concerned both companies’ pharmacy operations and claims under the federal False Claims Act and Minnesota False Claims Act. A whistleblower brought the civil lawsuit that led to the settlement. The government alleged that employees told managers about the violation, yet the automatic refills kept coming.

How Automatic Refills Became Medicaid Claims

At the time of the settlement, Minnesota’s Medicaid program, Medical Assistance, required an explicit beneficiary request for each refill. The condition put the patient’s decision between an existing prescription and the next government-paid supply of medicine.

According to the government’s allegations, Walmart and Sam’s Club pharmacies routinely enrolled Medical Assistance beneficiaries in the companies’ automatic-refill program and billed Medical Assistance for prescriptions that violated the state’s rules. A standing enrollment told the pharmacy to repeat the process. The state’s condition called for the beneficiary to ask again.

Medical Assistance provides health care to low-income Minnesotans with federal and state funding. The request requirement was a control against wasted or unnecessary prescriptions reimbursed with taxpayer money. Under the government’s account, the pharmacies kept generating claims while bypassing the patient decision the rule was meant to preserve.

Medicaid pharmacy payment operates at the state level within federal limits. In its announcement, the Justice Department described Minnesota and at least 20 other states as having this kind of refill restriction.

Employee Reports Put the Problem in Front of Managers

The government alleged that pharmacy employees reported the violation to company managers and that Walmart and Sam’s Club continued the automatic refills. The alleged problem had reached people who managed the operation while the operation kept producing the disputed prescriptions.

An employee’s account can connect what happened at the pharmacy with what management learned about it. We examine what the employee observed, what the report said about the refill process, who received it and what the business did afterward. Someone familiar with enrollment may understand how prescriptions entered the program, while someone handling claims or internal complaints may see where the problem reached the payment system or management.

The tension between the person dispensing medicine and the business setting the rules also appears in pharmacy scholarship. A University of Portsmouth doctoral thesis on pharmacists’ decision-making, dated 2020, describes the constraints employers place on pharmacists’ professional judgment:

That observation helps explain why the management reports matter here. The Walmart allegations put the pharmacy’s program and the response of its managers in the same account. An insider who understands both can help us see how a business practice continued after employees challenged it. That is a question about decisions inside the company, beyond what a claim for a refill says on its own.

A Federal and State Civil Resolution

The settlement allocated $412,500 to the federal government and the same amount to Minnesota. Both governments were recovering money for the healthcare program they fund. Walmart and Sam’s Club agreed to pay while denying wrongdoing, despite the government’s allegation that employees had already flagged the practice to managers.

The lawsuit began with a whistleblower using the qui tam provisions of the federal and Minnesota False Claims Acts, which let private parties bring cases on the government’s behalf and share in a recovery. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

What a Pharmacy Insider Can Connect

For a pharmacy whistleblower, the useful connection runs from enrollment through the refill and the Medicaid claim to the company’s response when employees raised the issue. Who or what initiated the refill? Where did the beneficiary’s request enter the process? What did the pharmacy bill, and what did managers learn?

We work through those connections with the person who understands the operation. Enrollment information, request records, refill histories, claims and internal communications can explain different parts of that account. An insider may know why a system treated a prescription as ready for another refill or how a complaint about the process moved through management. That knowledge helps us understand what the billing alone leaves unexplained.

When the Refill Conversation Serves the Business

The Exjade refill-counseling cases show another way a pharmacy’s business arrangements can shape the next prescription. In the BioScrip settlement announcement, the government described allegations that counseling encouraged Exjade refills under the influence of Novartis referrals and rebates while understating risks.

The government’s amended complaint described the work behind those calls. It alleged that a newly hired nurse began calling Exjade patients without training on the drug or its side effects. The instruction she allegedly received was revealing:

The same complaint alleged that Novartis threatened to cut off patient referrals or remove BioScrip from its pharmacy network unless the pharmacy raised refill levels. That gives the counseling allegation its business context: more refills could protect a source of new patients.

That case concerned pressure within the conversation encouraging a patient to order more medicine. The Walmart and Sam’s Club allegations concerned automatic refills without the required request. Together they show why the step that produces the next prescription deserves attention: the patient’s decision, the pharmacy’s business process and the government’s payment meet there.

Your Pharmacy Refill Whistleblower Case

If you saw Medicaid refills proceed without patient requests, or know what happened after employees raised the problem, talk with our whistleblower experts about the pharmacy’s decisions. We develop the case with you and bring in pharmaceutical fraud whistleblower lawyers who understand pharmacy billing and the records behind it. You bring knowledge of the operation, and we stay beside you to build your strongest pharmacy whistleblower case.